StockTipsArenaBeta

Divi's Laboratories Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹8,950-212.00 (-2.31%)
As of 23 Oct 2026

Avg 1-year target

4 of 7 long-term calls BUY

₹8,2427.9% below today's price

Divi's Laboratories' average 1-year share price target is ₹8,242, the average of 6 advisors' latest targets. Targets range from ₹5,227 to ₹11,700.

Latest: Jefferies India ₹10,200 · 4 Aug 2026

9
5 BUY · 4 SELL, all horizons
6
with an active 1Y target
52%
39 of 75 closed calls hit
85
all horizons, open and closed
Watch DIVISLAB for new buy/sell callsGet alertsSee 37 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips · page 2 of 2

← Back to filtered view
BUYTarget₹7,600
NJbyNilesh Jain, Centrum BrokingStop-loss hit
1–2 Weeks · 20 Jul 2026 · entry ₹7,417.5 · via Business Todayexit ₹7,250
BUYTarget₹7,550
ASbyAmit SethStop-loss hit
1–2 Weeks* · 20 Jul 2026 · entry ₹7,322 · via CNBC Awaaz.exit ₹7,200
BUYTarget₹6,886
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 23 Jun 2026 · entry ₹6,780 · via CNBC Awaaz.exit ₹6,706
BUYTarget₹6,925
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 18 Jun 2026 · entry ₹6,800 · via CNBC Awaaz.exit ₹6,699
BUYTarget₹6,819
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 16 Jun 2026 · entry ₹6,725 · via CNBC Awaaz.exit ₹6,658
BUYTarget₹11,100
SJbySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesExpired
1–2 Weeks* · 8 Sept 2026 · entry ₹9,375.5 · via NDTV Profit (Live)exit ₹9,352
BUYTarget₹10,000
ABbyArpit Beriwal, Motilal OswalExpired
1–2 Weeks* · 27 Aug 2026 · entry ₹9,049 · via ET Now (Live)exit ₹9,488
BUYTarget₹9,333
SJbySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesExpired
1–2 Weeks* · 12 Aug 2026 · entry ₹8,630 · via NDTV Profit (Live)exit ₹8,744.5
BUYTarget₹8,800
LSbyLaxmikant Shukla, YES SecuritiesExpired
1–2 Weeks* · 11 Aug 2026 · entry ₹8,630 · via ET Now (Live)exit ₹8,744.5
BUYTarget₹8,750
AJbyAastha Jain, Hem SecuritiesExpired
1–2 Weeks* · 11 Aug 2026 · entry ₹8,550 · via Zee Business (Live)exit ₹8,496
BUYTarget₹8,800
SHbySwati Hotkar, Nirmal Bang SecuritiesExpired
1–2 Weeks* · 11 Aug 2026 · entry ₹8,548 · via Zee Business (Live)exit ₹8,496
BUYTarget₹8,780
CTbyChandan Taparia, Motilal OswalExpired
1–2 Weeks* · 11 Aug 2026 · entry ₹8,498 · via Zee Business (Live)exit ₹8,496
BUYTarget₹7,750
RSbyRajesh SatputeExpired
1–2 Weeks* · 13 Jul 2026 · entry ₹6,830 · via CNBC Awaaz.exit ₹7,415
BUYTarget₹7,000
CTbyChandan Taparia, Motilal OswalExpired
1–2 Weeks* · 25 May 2026 · entry ₹6,600 · via ET Nowexit ₹6,521
BUYTarget₹10,000
PGbyPrakash GabaStop-loss hit
BTST · 8 Sept 2026 · entry ₹9,575 · via CNBC Awaaz.exit ₹9,400
BUYTarget₹6,700
RVbyRachna VaidyaStop-loss hit
BTST · 2 Jun 2026 · entry ₹6,600 · via CNBC Awaaz.exit ₹6,540
BUYTarget₹9,750
KJbyKavita Jain, Arihant Capital MarketsExpired
BTST · 6 Oct 2026 · entry ₹9,520.5 · via CNBC Awaaz.exit ₹9,596
BUYTarget₹8,520
PSbyPrashant Shah, Definedge Securities BrokingTarget hit
Intraday* · 11 Aug 2026 · entry ₹8,480 · via CNBC Awaaz.exit ₹8,520
BUYTarget₹7,150
PSbyPrashant Shah, Definedge Securities BrokingTarget hit
Intraday* · 14 Jul 2026 · entry ₹7,100 · via CNBC Awaaz.exit ₹7,150
BUYTarget₹7,100
NJbyNilesh Jain, Centrum BrokingTarget hit
Intraday* · 14 Jul 2026 · entry ₹7,070.5 · via CNBC Awaaz.exit ₹7,100
BUYTarget₹7,050
NMbyNooresh MeraniTarget hit
Intraday* · 14 Jul 2026 · entry ₹7,048 · via CNBC Awaaz.exit ₹7,050
BUYTarget₹6,900
RSbyRajesh SatputeTarget hit
Intraday* · 13 Jul 2026 · entry ₹6,815.5 · via CNBC Awaaz.exit ₹6,900
BUYTarget₹6,935
AKbyArun Kumar MantriTarget hit
Intraday* · 13 Jul 2026 · entry ₹6,836 · via CNBC Awaaz.exit ₹6,935
BUYTarget₹6,900
PGbyPrakash GabaTarget hit
Intraday* · 9 Jul 2026 · entry ₹6,831 · via CNBC Awaaz.exit ₹6,900
BUYTarget₹9,350
ABbyAshish Bahety, Profitmart SecuritiesStop-loss hit
Intraday* · 22 Oct 2026 · entry ₹9,150 · via CNBC Awaaz.exit ₹9,060
BUYTarget₹9,320
KBbyKunal BothraStop-loss hit
Intraday* · 16 Sept 2026 · entry ₹9,168 · via ET Now (Live)exit ₹9,080
BUYTarget₹8,650
PGbyPrakash GabaStop-loss hit
Intraday* · 25 Aug 2026 · entry ₹8,598 · via CNBC Awaaz.exit ₹8,570
BUYTarget₹7,600
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
Intraday* · 28 Jul 2026 · entry ₹7,440.5 · via CNBC Awaaz.exit ₹7,420
BUYTarget₹7,500
RSbyRahul Sharma, JM FinancialStop-loss hit
Intraday* · 27 Jul 2026 · entry ₹7,384 · via CNBC Awaaz.exit ₹7,250
BUYTarget₹7,000
RSbyRajesh SatputeStop-loss hit
Intraday · 23 Jun 2026 · entry ₹6,869.5 · via CNBC Awaaz.exit ₹6,790
BUYTarget₹9,500
PGbyPrakash GabaExpired
Intraday* · 18 Sept 2026 · entry ₹9,346.5 · via CNBC Awaaz.exit ₹9,373
BUYTarget₹8,850
CTbyChandan Taparia, Motilal OswalExpired
Intraday* · 12 Aug 2026 · entry ₹8,613 · via NDTV Profitexit ₹8,486.5
BUYTarget₹7,500
ABbyAkshay Bhagwat, JM Financial○ No trade
Intraday · 21 Jul 2026 · entry ₹7,225 · via ET Now
BUYTarget₹7,470
CTbyChandan Taparia, Motilal OswalExpired
Intraday · 15 Jul 2026 · entry ₹7,261.5 · via NDTV Profit (Live)exit ₹7,235.5
BUYTarget₹7,000
ABbyAshish Bahety, Profitmart SecuritiesExpired
Intraday* · 7 Jul 2026 · entry ₹6,857.5 · via CNBC Awaaz.exit ₹6,774

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

Showing 51–85 of 85